HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Barbara Cebula-Obrzut Selected Research

IRS 954

6/2013Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Barbara Cebula-Obrzut Research Topics

Disease

9Neoplasms (Cancer)
12/2018 - 10/2011
7B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2017 - 10/2012
5Breast Neoplasms (Breast Cancer)
12/2018 - 10/2011
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2015 - 10/2010
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2017 - 01/2014
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2014 - 12/2013
2Multiple Myeloma
10/2014 - 09/2013
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2014 - 09/2013
1Hematologic Neoplasms (Hematological Malignancy)
08/2015
1Burkitt Lymphoma (Burkitt's Lymphoma)
10/2014
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2014
1Carcinogenesis
01/2014
1Lymphoma (Lymphomas)
09/2013
1Necrosis
06/2013
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2013
1Disease Progression
03/2013
1Essential Thrombocythemia
12/2012
1Infections
01/2011
1Common Variable Immunodeficiency
01/2011

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
03/2017 - 10/2010
3Clofarabine (Clolar)FDA Link
12/2018 - 01/2014
3Interleukin-10 (Interleukin 10)IBA
10/2017 - 12/2012
2retinoic acid receptor betaIBA
12/2018 - 01/2014
2PhytochemicalsIBA
12/2018 - 01/2015
2Toll-Like Receptors (Toll-Like Receptor)IBA
10/2017 - 01/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2015 - 03/2013
2Rituximab (Mabthera)FDA Link
12/2014 - 10/2012
2ranpirnase (Pannon)IBA
07/2014 - 12/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 12/2012
1GenisteinIBA
12/2018
1Catechin (Z 7300)IBA
12/2018
1TeaIBA
12/2018
1Phytoestrogens (Phytoestrogen)IBA
12/2018
12'-deoxyadenosineIBA
12/2018
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
12/2018
1Therapeutic UsesIBA
12/2018
1NucleosidesIBA
12/2018
1PolyphenolsIBA
12/2018
1Interleukin-6 (Interleukin 6)IBA
10/2017
1triphenylmethaneIBA
07/2016
1honokiolIBA
07/2016
1CTLA-4 AntigenIBA
08/2015
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2015
1Programmed Cell Death 1 ReceptorIBA
08/2015
1CytokinesIBA
08/2015
1Jagged-1 ProteinIBA
02/2015
1Cisplatin (Platino)FDA LinkGeneric
01/2015
1AngiopoietinsIBA
01/2015
1Pharmaceutical PreparationsIBA
01/2015
1sulforaphaneIBA
01/2015
1Inhibitor of Apoptosis ProteinsIBA
01/2015
1SurvivinIBA
01/2015
1CaspasesIBA
12/2014
1Bendamustine HydrochlorideFDA Link
12/2014
1SMIP-016IBA
10/2014
1ofatumumabFDA Link
10/2014
1Ribonucleases (Ribonuclease)IBA
07/2014
1MethyltransferasesIBA
01/2014
1ElementsIBA
01/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2014
1Adenosine (Adenocard)FDA LinkGeneric
01/2014
1TensinsIBA
01/2014
1fludarabineIBA
01/2014
1IRS 954IBA
06/2013
1CladribineFDA LinkGeneric
06/2013
1Toll-Like Receptor 7IBA
06/2013
1Toll-Like Receptor 9IBA
06/2013
1Monoclonal AntibodiesIBA
03/2013
1Bevacizumab (Avastin)FDA Link
03/2013
1Caspase 3 (Caspase-3)IBA
10/2011
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
10/2011
1VaccinesIBA
01/2011
1Polysaccharides (Glycans)IBA
01/2011
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2011
1Staphylococcal Protein A (Protein A)IBA
10/2010

Therapy/Procedure

4Therapeutics
01/2015 - 01/2011
1VAP-cyclo protocol
12/2013
1Hematopoietic Stem Cell Transplantation
09/2013
1Drug Therapy (Chemotherapy)
09/2013